Communications with FDA by Early-Stage Companies - Problems and Solutions

Event Details


May 12, 2009

Add To Calendar



Early life science companies face many challenges when trying to obtain marketing authorization, not the least of which is communicating with FDA. This 90-minute webinar will be hosted by Alan Minsk, a partner at the law firm Arnall Golden Gregory, who has more than 16 years of experience advising small to mid-size pharmaceutical and medical device companies on FDA-related legal and regulatory matters. He will discuss common mistakes early-stage companies make when interacting with FDA and recommendations to improve such relationships. 

Question and answer session will follow.